TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34164829

Group type: EXPERIMENTAL
Intervention: QS‐Nd:YAG toning
Number of subjects: 30

Group type: COMPARATOR
Intervention: Low power fractional CO2 laser alone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combined QS‐Nd:YAG toning with low power fractional CO2
Number of subjects: 30
Study: 32199656

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate 50 mg/kg
Number of subjects: 68

Group type: COMPARATOR
Intervention: Rocuronium 1 mg/kg
Number of subjects: 68
Study: 35481889

Group type: EXPERIMENTAL
Intervention: N-VAR (fixed exercises)
Number of subjects: 23

Group type: COMPARATOR
Intervention: VAR (varied exercises)
Number of subjects: 23
Study: 33480045

Group type: EXPERIMENTAL
Intervention: N-acetyl cysteine (NAC)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 32463774

Group type: EXPERIMENTAL
Intervention: Pharmacist-led comprehensive chemotherapy consultation services
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (historical patients who received first cycle of chemotherapy)
Number of subjects: 96
Study: 36108891

Group type: EXPERIMENTAL
Intervention: Nivolumab plus Ipilimumab
Number of subjects: 13

Group type: COMPARATOR
Intervention: Nivolumab
Number of subjects: 13
Study: 33091403

Group type: EXPERIMENTAL
Intervention: Plasma-rich growth factor (PRGF)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (CTRL)
Number of subjects: 100
Study: 32044751

Group type: EXPERIMENTAL
Intervention: Run4Love program via WeChat
Number of subjects: 300

Group type: COMPARATOR
Intervention: Usual care and a brochure on nutrition for PLWH
Number of subjects: 300
Study: 35727080

Group type: EXPERIMENTAL
Intervention: Family Planning Counseling (intervention)
Number of subjects: 19155

Group type: EXPERIMENTAL
Intervention: Antenatal family planning counseling (intervention)
Number of subjects: 19155

Group type: EXPERIMENTAL
Intervention: PPIUD-specific counseling (intervention)
Number of subjects: 19155

Group type: EXPERIMENTAL
Intervention: Postnatal family planning counseling (spillover effect)
Number of subjects: 19155
Study: 33774594

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (1g administered intravenously upon induction of anaesthesia)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Normal saline infusion (control)
Number of subjects: 93
Study: 35959201

Group type: EXPERIMENTAL
Intervention: Low-power visible-light-activated photodynamic therapy (PDT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32867852

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) plus standard personal protective equipment (PPE) - 800mg loading dose on day of randomization (two 400mg doses 12 hours apart), followed by 400mg once a week for 12 weeks.
Number of subjects: 6950

Group type: COMPARATOR
Intervention: Standard personal protective equipment (PPE) alone.
Number of subjects: 6950

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) plus standard PPE.
Number of subjects: 6950
Study: 36453309

Group type: EXPERIMENTAL
Intervention: Pilocarpine eye drops
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Low Van Herick grades (217 eyes)
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Narrow gonioscopy grades (238 eyes)
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Narrow OCT angle value (165 eyes)
Number of subjects: 273
Study: 34884230

Group type: EXPERIMENTAL
Intervention: Eccentric exercise
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Concentric exercise
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Isometric exercise
Number of subjects: 69

Group type: COMPARATOR
Intervention: No exercise (Control)
Number of subjects: 69
Study: 33955162

Group type: EXPERIMENTAL
Intervention: 105 mg edaravone oral suspension
Number of subjects: 42

Group type: COMPARATOR
Intervention: 60 mg intravenous edaravone
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 42
Study: 33087177

Group type: EXPERIMENTAL
Intervention: People with obesity (PwO)
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Physicians
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: People with obesity (PwO) and physicians
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Healthcare professionals (HCPs)
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Dietitians
Number of subjects: 750
Study: 35683988

Group type: EXPERIMENTAL
Intervention: Nutri-Score (N-S)
Number of subjects: 4530

Group type: EXPERIMENTAL
Intervention: Multiple Traffic Lights (MTL)
Number of subjects: 4530

Group type: EXPERIMENTAL
Intervention: Warning Label (WL)
Number of subjects: 4530

Group type: EXPERIMENTAL
Intervention: Positive Choice tick (PC)
Number of subjects: 4530

Group type: COMPARATOR
Intervention: no-label control
Number of subjects: 4530

Group type: EXPERIMENTAL
Intervention: N-S, MTL, WL
Number of subjects: 4530
Study: 32321450

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Sodium-potassium citrate
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard therapy group without any alkalinizing agents
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate, Sodium-potassium citrate, Standard therapy
Number of subjects: 150
Study: 36379437

Group type: EXPERIMENTAL
Intervention: Alcohol Telemedicine Consult (ATC) Service, including alcohol pharmacotherapy and SBIRT delivered by clinical pharmacists
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual Care (UC) arm providing systematic alcohol SBIRT
Number of subjects: 0
Study: 32034673

Group type: EXPERIMENTAL
Intervention: Comprehensive evaluation via a chest pain unit (CPU) for patients ≥ 65 years
Number of subjects: 1220

Group type: COMPARATOR
Intervention: Comprehensive evaluation via a chest pain unit (CPU) for patients < 65 years
Number of subjects: 1220
Study: 35042448

Group type: EXPERIMENTAL
Intervention: Low-dose combination of amlodipine 5 mg plus bisoprolol 5 mg
Number of subjects: 439

Group type: COMPARATOR
Intervention: Amlodipine 10 mg
Number of subjects: 439
Study: 32707579

Group type: EXPERIMENTAL
Intervention: Supervised moderate-to-high-intensity progressive resistance training
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Home-based resistance training
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study: 35844443

Group type: EXPERIMENTAL
Intervention: Collaborative family nursing interventions
Number of subjects: 144

Group type: COMPARATOR
Intervention: Nursing interventions including health education, psychological intervention, medication guidance, complication prevention, and follow-up management
Number of subjects: 144
Study: 33277124

Group type: EXPERIMENTAL
Intervention: Hyperspectral imaging (HSI) for fat quantification in shelled beans
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Hyperspectral imaging (HSI) for fat quantification in in‐shell beans
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Manual segregation of beans
Number of subjects: 170
Study: 32078379

Group type: EXPERIMENTAL
Intervention: Child-Directed Interaction - Toddler (CDI-T)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 66
Study: 34674258

Group type: EXPERIMENTAL
Intervention: Letermovir
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34154795

Group type: EXPERIMENTAL
Intervention: Cidofovir
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 16
Study: 32011402

Group type: EXPERIMENTAL
Intervention: Tilt-Down (TD) positioning
Number of subjects: 150

Group type: COMPARATOR
Intervention: Left Lateral (LL) positioning
Number of subjects: 150
Study: 36196400

Group type: EXPERIMENTAL
Intervention: Eccentric isokinetic training
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Concentric isokinetic training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Between-group analysis
Number of subjects: 30
Study: 35190439

Group type: EXPERIMENTAL
Intervention: Machine learning-based patient decision aid (PDA) integrating patient-reported outcomes and clinical variables.
Number of subjects: 200

Group type: COMPARATOR
Intervention: Patient-reported outcomes (PROMs) and shared decision-making (SDM) process.
Number of subjects: 200
Study: 33066081

Group type: EXPERIMENTAL
Intervention: n‐3 PUFA‐enriched hen eggs (two eggs per day, for three weeks, total of approximately 407 mg/day n‐3 PUFAs)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Regular eggs (two eggs per day for three weeks, total of approximately 75 mg/day n‐3 PUFAs)
Number of subjects: 20
Study: 35109598

Group type: EXPERIMENTAL
Intervention: Video conferencing telehealth (n=30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Telephone-only telehealth (n=30)
Number of subjects: 60
Study: 32203892

Group type: EXPERIMENTAL
Intervention: CGX 1 g
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: CGX 2 g
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: CGX 1 g (without antiviral use)
Number of subjects: 67
Study: 35439567

Group type: COMPARATOR
Intervention: Semaglutide 2.4 mg once weekly
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Semaglutide plus cilofexor 30 mg
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Semaglutide plus cilofexor 100 mg
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Semaglutide plus firsocostat 20 mg
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Semaglutide, cilofexor 30 mg and firsocostat
Number of subjects: 108
Study: 33499545

Group type: EXPERIMENTAL
Intervention: Graduated Exercise Program (GEP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard-of-care exercise program
Number of subjects: 0
Study: 36210793

Group type: EXPERIMENTAL
Intervention: Idiopathic uveitis
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Uveitis due to juvenile idiopathic arthritis (JIA)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Uveitis due to Behçet's disease (BD)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Complications related to uveitis
Number of subjects: 97
Study: 33704466

Group type: EXPERIMENTAL
Intervention: OJ with 5 g fiber from OP (OPF)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Whole Orange Fruit (WOF)
Number of subjects: 62

Group type: COMPARATOR
Intervention: OJ
Number of subjects: 62
Study: 33536047

Group type: EXPERIMENTAL
Intervention: 1 g of IV tranexamic acid (TXA) at admission
Number of subjects: 125

Group type: COMPARATOR
Intervention: Normal saline (NS)
Number of subjects: 125
Study: 35112378

Group type: EXPERIMENTAL
Intervention: Subcutaneous tanezumab (2.5–10 mg every 8 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous tanezumab (2.5–20 mg every 8 weeks for up to 56 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment-emergent anti-drug antibodies (TE ADA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baseline nerve growth factor (NGF)
Number of subjects: 0
Study: 33012216

Group type: EXPERIMENTAL
Intervention: Whey protein (PRO; 60 g/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Carbohydrate (CON)
Number of subjects: 40
Study: 32912199

Group type: EXPERIMENTAL
Intervention: Job retention vocational rehabilitation (JRVR) plus a self-help written work advice pack and usual care
Number of subjects: 240

Group type: COMPARATOR
Intervention: Self-help written work advice pack plus usual care
Number of subjects: 240
Study: 35450050

Group type: EXPERIMENTAL
Intervention: Remdesivir + Tocilizumab
Number of subjects: 100

Group type: COMPARATOR
Intervention: Dexamethasone
Number of subjects: 100
Study: 36368911

Group type: EXPERIMENTAL
Intervention: Educational video promoting paternal involvement in childcare
Number of subjects: 451

Group type: COMPARATOR
Intervention: Educational video on the prevention of shaken baby syndrome (Control)
Number of subjects: 451
Study: 33432157

Group type: EXPERIMENTAL
Intervention: Epo 1000 U/kg
Number of subjects: 628

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 628
Study: 33268476

Group type: COMPARATOR
Intervention: NSAIDs (non-steroidal anti-inflammatory drugs) as a strong opioid adjunct
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Oral administration of NSAIDs
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Selective COX-2 inhibitors and non-selective COX-2 inhibitors
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: NSAIDs
Number of subjects: 223
Study: 35889835

Group type: EXPERIMENTAL
Intervention: Flaxseed supplementation (28 g/day) for 10 weeks in group 1 (lean patients with severe dyslipidaemia)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Flaxseed supplementation (28 g/day) for 10 weeks in group 2 (obese patients with mild dyslipidaemia)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Flaxseed supplementation (28 g/day) for both groups
Number of subjects: 22

Group type: COMPARATOR
Intervention: Ordinary diet + placebo in group 1
Number of subjects: 22

Group type: COMPARATOR
Intervention: Ordinary diet in group 2
Number of subjects: 22
Study: 33656480

Group type: EXPERIMENTAL
Intervention: Telephone-based education and navigation program
Number of subjects: 14
Study: 32000141

Group type: EXPERIMENTAL
Intervention: Endurance training (95% of ventilatory threshold 2 for 1 hour)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (6 × 30-second intervals at 175% peak power output with 4.5-minute rest)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: RPE across endurance and high-intensity interval training sessions
Number of subjects: 18
Study: 35685985

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 63

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 63
Study: 32790496

Group type: EXPERIMENTAL
Intervention: Maytenus ilicifolia extract (MIE)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 33725766

Group type: EXPERIMENTAL
Intervention: Cocktail group
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: TBBr group
Number of subjects: 90

Group type: COMPARATOR
Intervention: BALF group
Number of subjects: 90
Study: 35229253

Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 130

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 130
Study: 33831843

Group type: EXPERIMENTAL
Intervention: intermittent warm-up + NaHCO3 (IWSB)
Number of subjects: 8

Group type: COMPARATOR
Intervention: control warm-up + NaHCO3 (CWSB)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: intermittent warm-up + placebo
Number of subjects: 8

Group type: COMPARATOR
Intervention: control warm-up + placebo (CWP)
Number of subjects: 8
Study: 35027932

Group type: EXPERIMENTAL
Intervention: Low current intensity electroacupuncture (EA)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: High current intensity electroacupuncture (EA)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Loperamide (control)
Number of subjects: 73
Study: 32421350

Group type: EXPERIMENTAL
Intervention: Endothelium-dependent dilation (EDD) in women
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Endothelium-independent dilation (EID) in younger men and women (<55 years)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EDD and EID in younger women vs younger men
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diabetes impact on EID
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blood pressure and cardiovascular disease impact on EDD and EID
Number of subjects: 0
Study: 36069480

Group type: EXPERIMENTAL
Intervention: Implant Surface Culture (ISC)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard Tissue Sampling Culture (TSC)
Number of subjects: 42
Study: 36324867

Group type: EXPERIMENTAL
Intervention: PP-Script (pre-procedure script)
Number of subjects: 160

Group type: COMPARATOR
Intervention: PX-Script (pre-extubation script)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Both PP-and PX-Scripts
Number of subjects: 160

Group type: COMPARATOR
Intervention: No script read
Number of subjects: 160
Study: 32699909

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (two cycles of methotrexate, doxorubicin, vinblastine, and cisplatin) followed by radical cystectomy
Number of subjects: 99

Group type: COMPARATOR
Intervention: Radical cystectomy alone
Number of subjects: 99
Study: 32174638

Group type: EXPERIMENTAL
Intervention: Noise levels in the red section
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Noise levels in the navy section
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Low frequency noise levels (0.05 to 1 kHz)
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: General attitude towards noise exposure
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Consideration of earplugs
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Experience of hearing muffled speech
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Need for information announcement
Number of subjects: 344
Study: 36104523

Group type: EXPERIMENTAL
Intervention: Open globe penetrating injuries
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Previous eye surgery, visual axis corneal scar, lens status, hyphaemia, vitreous haemorrhaging
Number of subjects: 280
Study: 32860813

Group type: EXPERIMENTAL
Intervention: Participants with keratoconus (15 participants)
Number of subjects: 1259

Group type: COMPARATOR
Intervention: Participants without keratoconus
Number of subjects: 1259

Group type: EXPERIMENTAL
Intervention: Participants with keratoconus
Number of subjects: 1259

Group type: EXPERIMENTAL
Intervention: Regular cigarette smoking
Number of subjects: 1259
Study: 32379107

Group type: EXPERIMENTAL
Intervention: Auricular acupressure intervention for 4 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group received skin tape without a seed for 4 weeks
Number of subjects: 60
Study: 35030447

Group type: EXPERIMENTAL
Intervention: Positive Psychotherapy for Psychosis (PPP), 13-session intervention based on a Cantonese Chinese translation of the PPP manual
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Positive Psychotherapy for Psychosis (PPP)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control group (treatments as usual)
Number of subjects: 154
Study: 34041570

Group type: EXPERIMENTAL
Intervention: Advanced Spatial Noise Reduction (ASNR) algorithm
Number of subjects: 270

Group type: COMPARATOR
Intervention: Conventional algorithm
Number of subjects: 270
Study: 32274986

Group type: EXPERIMENTAL
Intervention: Hollow fiber ultrafilter (HFU) distributed to intervention households, used for household water treatment over a 1-year period.
Number of subjects: 166

Group type: COMPARATOR
Intervention: Comparison households (no HFU intervention).
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Hollow fiber ultrafilter (HFU) intervention.
Number of subjects: 166
Study: 35817646

Group type: EXPERIMENTAL
Intervention: Patient-level intervention
Number of subjects: 2200

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 2200
Study: 32320639

Group type: EXPERIMENTAL
Intervention: Pre-existing auditory symptoms
Number of subjects: 936

Group type: EXPERIMENTAL
Intervention: Audiometric testing for hearing loss
Number of subjects: 936

Group type: EXPERIMENTAL
Intervention: Age ≥ 50 years
Number of subjects: 936

Group type: EXPERIMENTAL
Intervention: Prior history of second-line TB treatment
Number of subjects: 936

Group type: EXPERIMENTAL
Intervention: HIV with CD4 count < 200 cells/mm3
Number of subjects: 936

Group type: EXPERIMENTAL
Intervention: Malnutrition
Number of subjects: 936
Study: 616330511

Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate vaccine (7vPCV) in a 0-1-2 month schedule
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate vaccine (7vPCV) in a 1-2-3 month schedule
Number of subjects: 312

Group type: COMPARATOR
Intervention: Control group (no 7vPCV)
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate vaccine (7vPCV) recipients
Number of subjects: 312
Study: 34819012

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 plus atomoxetine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo plus atomoxetine
Number of subjects: 60
Study: 34449189

Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 mg once daily)
Number of subjects: 5988

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5988
Study: 36127121

Group type: EXPERIMENTAL
Intervention: VR intervention (Alfi) for 8 weeks, 14 sessions of 20 minutes each
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: VR intervention (Alfi)
Number of subjects: 100
Study: 33989338

Group type: EXPERIMENTAL
Intervention: Walking behavior change (daily step count)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Critical fluctuations in walking behavior
Number of subjects: 151
Study: 35863358

Group type: EXPERIMENTAL
Intervention: Procalcitonin-guided care
Number of subjects: 260

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 260
Study: 33881657

Group type: EXPERIMENTAL
Intervention: Single-port robotic transanal total mesorectal excision (SP rTaTME)
Number of subjects: 2
Study: 34951503

Group type: EXPERIMENTAL
Intervention: Groupwise Autonomy Enhancing Treatment (AET)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Groupwise Cognitive Behavioral Therapy (CBT)
Number of subjects: 129
Study: 34175276

Group type: EXPERIMENTAL
Intervention: Walking (steps/day) assessed at 6 weeks after spine surgery
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Walking ≥3500 steps/day
Number of subjects: 248
Study: 32387472

Group type: EXPERIMENTAL
Intervention: Folinic acid (FOLINORAL®) 5 mg twice daily
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 35748074

Group type: EXPERIMENTAL
Intervention: IL-17A
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 0
Study: 34455431

Group type: EXPERIMENTAL
Intervention: Single fraction of 28 Gy
Number of subjects: 90

Group type: COMPARATOR
Intervention: Multifraction of 4 fractions of 12 Gy
Number of subjects: 90
Study: 36409491

Group type: EXPERIMENTAL
Intervention: Dual pathway inhibition (rivaroxaban 2.5 mg twice daily plus aspirin 100 mg daily)
Number of subjects: 27395

Group type: EXPERIMENTAL
Intervention: Rivaroxaban monotherapy (5 mg twice daily)
Number of subjects: 27395

Group type: COMPARATOR
Intervention: Aspirin monotherapy (100 mg once daily)
Number of subjects: 27395
Study: 34750564

Group type: EXPERIMENTAL
Intervention: 0.6 g/kg dose of alcohol
Number of subjects: 264

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 264